Myasthenia-specific antibodies (acetylcholine receptor (AChR), muscle-specific kinase (MuSK), low-density lipoprotein receptor (LRP4)) may be positive, indicating the presence of concurrent myasthenia, especially when ocular or bulbar symptoms are predominant [44,47]. The gene discussed is LRP4; the disease is Fatigable weakness.